Robeco Institutional Asset Management B.V. Harmony Biosciences Holdings, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $60.3 Billion
- Q2 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 46,787 shares of HRMY stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,787Holding current value
$1.72 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
280Shares Held
45MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$243 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$214 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$57.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$47.3 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.17B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...